Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
Sign Up to like & getrecommendations! Published in 2020 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2020.102971
Abstract: Background In neuroblastoma, genetic alterations in ATRX, define a distinct poor outcome patient subgroup. Despite the need for new therapies, there is a lack of available models and a dearth of pre-clinical research. Methods To… read more here.
Keywords: dna damage; atrx mutant; atrx; sensitivity ... See more keywords